Key facts: Strive Reports Q3 Results; Raises $609M; Ends Device R&D
Strive (ASST) reported Q3 2026 revenue of $2.7M, net income of $509M including $533.7M in Bitcoin gains, and operating expenses of $38.7M. The company raised $609M via a preferred shares offering and ended R&D on a medical-device product. HC Wainwright maintained a Buy rating but lowered its price target to $40.
How this was made
The 30-second read
Why it matters
The $609M raise is a significant liquidity event; combined with a $533.7M unrealized Bitcoin gain, it reshapes the company's financial outlook.
Market read
First‑time disclosure of a sizable capital raise and crypto‑driven earnings for a micro‑cap, likely to move the stock in pre‑market trading.
What to watch
Potential regulatory scrutiny of crypto‑related earnings and the sustainability of unrealized gains.
Background
Strive (ASST) is a micro‑cap focused on crypto‑linked assets, recently expanding its capital base via preferred shares.
Ticker impact
Strive reported Q3 2026 revenue, net income and a $609M preferred share offering, all disclosed for the first time.
likely downward pressure as the market prices dilution from the $609M preferred share issuance
The unprecedented raise size for a micro‑cap and the unrealized Bitcoin gains are new material facts that can move the stock immediately.
Market effects
Highlights growing crypto exposure in micro‑caps and may prompt scrutiny of similar Bitcoin‑linked balance sheets.
Primarily U.S. micro‑cap investors; limited broader regional effect.
Shows continued investor appetite for crypto‑linked capital raises.
Counterpoint
The Bitcoin gains could offset dilution concerns, making the stock a short‑term upside play.
Key entities
- companyStrive, Inc.
Issuer of the ASST ticker, reporting Q3 results and a large preferred share offering.
- analystHC Wainwright & Co.
Maintained Buy rating and adjusted price target for Strive.
